Tracing the voyage of SELDI-TOF MS in cancer biomarker discovery and its current depreciation trend - need for resurrection?

被引：14

作者：

Muthu, Manikandan ^{[1
]}

Vimala, A. ^{[2
]}

Mendoza, Ordetta Hanna ^{[3
]}

Gopal, Judy ^{[1
]}

机构：

[1] Konkuk Univ, Dept Bioresource & Food Sci, Seoul 143701, South Korea

[2] Indian Inst Technol Madras, Dept Biotechnol, Chennai 600036, Tamil Nadu, India

[3] Stella Maris Coll, Dept Bot, Madras 600086, Tamil Nadu, India

来源：

TRAC-TRENDS IN ANALYTICAL CHEMISTRY | 2016年 / 76卷

关键词：

SELDI-TOF MS; Cancer biomarker; Limitation; Proteomics; Clinical; Resurrection; Decline; LASER-DESORPTION/IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; OVARIAN-CANCER; CLINICAL PROTEOMICS; CEREBROSPINAL-FLUID; SERUM BIOMARKERS; RENAL-CANCER; IDENTIFICATION; TECHNOLOGY; DIAGNOSIS;

D O I：

10.1016/j.trac.2015.10.004

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

Surface-enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF MS) has been established as a powerful analytical tool for biomarker discovery in oncology. This review visits the milestones achieved by this technique and scans the advantages and limitation of the technique as well. The need for expanding this technique for biomarker discovery with respect to diseases other than cancer has been emphasized. The future of this technique and its application to clinical research has been highlighted to have hit a dead-end. This review is an eye opener to break the silence, amidst the analytical chemists for revival of this technique, breaking barriers in its application to clinical research. (C) 2015 Elsevier B.V. All rights reserved.

引用

页码：95 / 101

页数：7

共 9 条

[1] Reproducible Cancer Biomarker Discovery in SELDI-TOF MS Using Different Pre-Processing Algorithms
Zou, Jinfeng
Hong, Guini
Guo, Xinwu
Zhang, Lin
Yao, Chen
Wang, Jing
Guo, Zheng
PLOS ONE, 2011, 6 (10):
[2] SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics
Simpkins, F
Czechowicz, JA
Liotta, L
Kohn, EC
PHARMACOGENOMICS, 2005, 6 (06) : 647 - 653
[3] Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS
Xue, Aiqun
Gandy, Robert C.
Chung, Liping
Baxter, Robert C.
Smith, Ross C.
PANCREATOLOGY, 2012, 12 (02) : 124 - 129
[4] Biomarker discovery for ovarian cancer using SELDI-TOF-MS
Zhang, Hui
Kong, Beihua
Qu, Xun
Jia, Lin
Deng, Biping
Yang, Qifeng
GYNECOLOGIC ONCOLOGY, 2006, 102 (01) : 61 - 66
[5] SELDI-TOF MS-based discovery of a biomarker in Cucumis sativus seeds exposed to CuO nanoparticles
Moon, Young-Sun
Park, Eun-Sil
Kim, Tae-Oh
Lee, Hoi-Seon
Lee, Sung-Eun
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2014, 38 (03) : 922 - 931
[6] Biomarker discovery with SELDI-TOF MS in human urine associated with early renal injury: Evaluation with computational analytical tools
Vanhoutte, Kurt J. A.
Laarakkers, Coby
Marchiori, Elena
Pickkers, Peter
Wetzels, Jack F. M.
Willems, Johannes L.
van den Heuvel, Lambert P.
Russel, Frans G. M.
Masereeuw, Rosalinde
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (10) : 2932 - 2943
[7] Cancer biomarker discovery;: a novel approach to obtain increased proteomic coverage in serum profiles using SELDI-TOF
Pernemalm, M.
Lehtio, J.
Lewensohn, R.
De Petris, L.
Koy, H.
Branden, E.
Brattstrom, D.
MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S125 - S125
[8] Proteomic profiling of ovine serum by SELDI-TOF MS: Optimisation, reproducibility and feasibility of biomarker discovery using routinely collected samples
Zhong, Ling
Taylor, Deborah L.
Whittington, Richard J.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2010, 33 (01) : 47 - 63
[9] SELDI-TOF MS profiling of fractionated plasma from retinol-deficient rats: a novel tool for biomarker discovery in nutrition research
Linke, T
Ross, AC
Harrison, EH
FASEB JOURNAL, 2004, 18 (04): : A499 - A499

← 1 →